Nuvalent Insider Balcom Files Form 144 for Proposed Securities Sale

TL;DR

**Nuvalent insider Balcom is looking to sell shares, watch for potential stock price dip.**

AI Summary

Alexandra Balcom, an insider at Nuvalent, Inc., has filed a Form 144 indicating her intent to sell company securities. This filing, dated March 24, 2026, signals a potential reduction in her ownership stake. For investors, this could be interpreted as a lack of confidence from an insider, potentially putting downward pressure on Nuvalent's stock price if the sale is executed.

Why It Matters

Insider selling can sometimes signal that those closest to the company believe the stock is fully valued or that future prospects are less bright, which could influence other investors' decisions.

Risk Assessment

Risk Level: medium — Insider selling, while not always negative, can sometimes precede a decline in stock price, creating a medium risk for current or prospective investors.

Analyst Insight

A smart investor would monitor Nuvalent's stock performance closely for any signs of selling pressure following this filing and consider the potential implications of an insider reducing their stake.

Key Players & Entities

• Alexandra Balcom (person) — Reporting person proposing to sell securities
• Nuvalent, Inc. (company) — Subject company whose securities are being proposed for sale
• 0001862147 (person) — CIK for Alexandra Balcom
• 0001861560 (company) — CIK for Nuvalent, Inc.

Forward-Looking Statements

• Nuvalent's stock price may experience downward pressure if Alexandra Balcom executes the proposed sale of securities. (Nuvalent, Inc.) — medium confidence, target: Within 3 months of March 24, 2026

FAQ

Filing Documents

• primary_doc.html (144)
• primary_doc.xml (144) — 4KB
• 0001968582-26-000319.txt ( ) — 6KB

From the Filing

Form 144 Filer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 FORM 144 144: Filer Information Is this a LIVE or TEST Filing? LIVE TEST Submission Contact Information Name Phone E-Mail Address 144: Issuer Information Name of Issuer Nuvalent, Inc. Address of Issuer One Broadway, 14th floor Cambridge MASSACHUSETTS 02142 Phone 8573577000 Name of Person for Whose Account the Securities are To Be Sold Alexandra Balcom See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice. Relationship to Issuer Officer 144: Securities Information Title of the Class of Securities To Be Sold Name and Address of the Broker Number of Shares or Other Units To Be Sold Aggregate Market Value Number of Shares or Other Units Outstanding Approximate Date of Sale Name the Securities Exchange Class A Common J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York � NY � 10017 59420 5729870 73181747 03/24/2026 NASDAQ Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor: 144: Securities To Be Sold Title of the Class Date you Acquired Nature of Acquisition Transaction Name of Person from Whom Acquired Is this a Gift? Date Donor Acquired Amount of Securities Acquired Date of Payment Nature of Payment * Class A Common 03/24/2026 NQ Stock Options Issuer 30019 03/24/2026 Cash Class A Common 03/24/2026 NQ Stock Options Issuer 15701 03/24/2026 Cash Class A Common 12/17/2024 ISO Exercise & Hold Issuer 4728 12/17/2024 Cash Class A Common 12/17/2024 ISO Exercise & Hold Issuer 8972 12/17/2024 Cash * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid. Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold. 144: Securities Sold During The Past 3 Months Nothing to Report 144: Remarks and Signature Remarks Date of Notice 03/24/2026 Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1 12/23/2025 ATTENTION: The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date. Signature /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Alexandra Balcom ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

View Full Filing

View this 144 filing on SEC EDGAR